TREA

Mirati Therapeutics Inc.

Follow

Organization

  • Ticker Symbols
    NASDAQ:MRTX
  • PHARMACEUTICAL PREPARATIONS
  • Business Address
    9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
  • Mailing Address
    9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
  • State Location
    CA
  • State of Incorporation
    DE
Organizations

Patents Grantslast 30 patents

  • Information Patent Grant

    KRas G12D inhibitors
    • Patent number 11,964,989
    • Issue date Apr 23, 2024
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRas G12C inhibitors
    • Patent number 11,932,633
    • Issue date Mar 19, 2024
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Combination therapies
    • Patent number 11,890,285
    • Issue date Feb 6, 2024
    • Mirati Therapeutics, Inc.
    • David Briere
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    SOS1 inhibitors
    • Patent number 11,702,418
    • Issue date Jul 18, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRas G12C inhibitors
    • Patent number 11,548,888
    • Issue date Jan 10, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    MTA-cooperative PRMT5 inhibitors
    • Patent number 11,492,351
    • Issue date Nov 8, 2022
    • Mirati Therapeutics, Inc.
    • Thomas P. Bobinski
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
    • Patent number 11,485,738
    • Issue date Nov 1, 2022
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    MTA-cooperative PRMT5 inhibitors
    • Patent number 11,479,551
    • Issue date Oct 25, 2022
    • Mirati Therapeutics, Inc.
    • Thomas P. Bobinski
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    KRas G12D inhibitors
    • Patent number 11,453,683
    • Issue date Sep 27, 2022
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRAS G12C inhibitors
    • Patent number 11,267,812
    • Issue date Mar 8, 2022
    • Mirati Therapeutics, Inc.
    • John P. Fischer
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
    • Patent number 11,220,509
    • Issue date Jan 11, 2022
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
    • Patent number 11,091,495
    • Issue date Aug 17, 2021
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRas G12C inhibitors
    • Patent number 10,689,377
    • Issue date Jun 23, 2020
    • Mirati Therapeutics, Inc.
    • James F. Blake
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    KRas G12C inhibitors
    • Patent number 10,647,715
    • Issue date May 12, 2020
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRas G12C inhibitors
    • Patent number 10,633,381
    • Issue date Apr 28, 2020
    • Mirati Therapeutics, Inc.
    • James F. Blake
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    EZH2 inhibitors
    • Patent number 10,266,542
    • Issue date Apr 23, 2019
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    LSD1 inhibitors
    • Patent number 10,233,152
    • Issue date Mar 19, 2019
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRas G12C inhibitors
    • Patent number 10,125,134
    • Issue date Nov 13, 2018
    • Mirati Therapeutics, Inc.
    • James F. Blake
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    LSD1 inhibitors
    • Patent number 10,059,668
    • Issue date Aug 28, 2018
    • Mirati Therapeutics, Inc.
    • Arkadii Vaisburg
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    LSD1 inhibitors
    • Patent number 9,809,541
    • Issue date Nov 7, 2017
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    COMBINATION THERAPIES
    • Publication number 20240156821
    • Publication date May 16, 2024
    • Mirati Therapeutics, Inc.
    • David Briere
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    KRAS G12C INHIBITORS
    • Publication number 20240101553
    • Publication date Mar 28, 2024
    • Mirati Therapeutics, Inc.
    • Matthew Arnold MARX
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KRAS G12D INHIBITORS
    • Publication number 20240034733
    • Publication date Feb 1, 2024
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    QUINAZOLINE PAN-KRas INHIBITORS
    • Publication number 20240025907
    • Publication date Jan 25, 2024
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    METHODS FOR TREATMENT OF LUNG CANCERS
    • Publication number 20230383359
    • Publication date Nov 30, 2023
    • Mirati Therapeutics, Inc.
    • James Gail Christensen
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    KRAS G12C INHIBITORS
    • Publication number 20230373999
    • Publication date Nov 23, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold MARX
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    KRAS G12D INHIBITORS
    • Publication number 20230357277
    • Publication date Nov 9, 2023
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CRYSTALLINE FORMS OF A KRAS G12C INHIBITOR
    • Publication number 20230357231
    • Publication date Nov 9, 2023
    • Mirati Therapeutics, Inc.
    • Patricia Andres
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    KRAS G12D INHIBITORS
    • Publication number 20230339976
    • Publication date Oct 26, 2023
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMBINATION THERAPIES
    • Publication number 20230321062
    • Publication date Oct 12, 2023
    • Mirati Therapeutics, Inc.
    • Hirak Der-Torossian
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    SOS1 INHIBITORS
    • Publication number 20230312482
    • Publication date Oct 5, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KRAS G12D INHIBITORS
    • Publication number 20230279025
    • Publication date Sep 7, 2023
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED IMIDAZO[1,2-c]PYRIMIDINES AS PRC2 INHIBITORS
    • Publication number 20230137025
    • Publication date May 4, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SOS1 INHIBITORS
    • Publication number 20230137886
    • Publication date May 4, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SOS1 INHIBITORS
    • Publication number 20230101312
    • Publication date Mar 30, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Azaquinazoline pan-KRas inhibitors
    • Publication number 20230072276
    • Publication date Mar 9, 2023
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KRAS G12D INHIBITORS
    • Publication number 20230077225
    • Publication date Mar 9, 2023
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MTA-Cooperative PRMT5 Inhibitors
    • Publication number 20230054883
    • Publication date Feb 23, 2023
    • Mirati Therapeutics, Inc.
    • Thomas P. Bobinski
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    CRYSTALLINE FORM OF A MULTI-TYROSINE KINASE INHIBITOR, METHOD OF PR...
    • Publication number 20220402936
    • Publication date Dec 22, 2022
    • Mirati Therapeutics, Inc.
    • Franck Raeppel
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    Combination Therapies Using PRMT5 Inhibitors for the Treatment of C...
    • Publication number 20220331323
    • Publication date Oct 20, 2022
    • Mirati Therapeutics, Inc.
    • Lars Daniel Engstrom
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    Combination Therapies Using PRMT5 Inhibitors for the Treatment of C...
    • Publication number 20220331324
    • Publication date Oct 20, 2022
    • Mirati Therapeutics, Inc.
    • Lars Daniel Engstrom
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CRYSTALLINE SALT OF A MULTI-TYROSINE KINASE INHIBITOR, METHOD OF PR...
    • Publication number 20220289760
    • Publication date Sep 15, 2022
    • Mirati Therapeutics, Inc.
    • Patricia Andres
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    IMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES AS PRC2 INHIBITORS FOR TREATIN...
    • Publication number 20220274990
    • Publication date Sep 1, 2022
    • Mirati Therapeutics, Inc.
    • Matthew Arnold MARX
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NAPHTHYRIDINE DERIVATIVES AS PRC2 INHIBITORS
    • Publication number 20220213097
    • Publication date Jul 7, 2022
    • Mirati Therapeutics, Inc.
    • John Michael KETCHAM
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMBINATION THERAPIES
    • Publication number 20220096482
    • Publication date Mar 31, 2022
    • Mirati Therapeutics, Inc.
    • James Gail Christensen
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMBINATION THERAPIES
    • Publication number 20220079947
    • Publication date Mar 17, 2022
    • Mirati Therapeutics, Inc.
    • James Gail Christensen
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMBINATION THERAPIES
    • Publication number 20220054491
    • Publication date Feb 24, 2022
    • Mirati Therapeutics, Inc.
    • James Gail Christensen
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMBINATION THERAPIES
    • Publication number 20220054492
    • Publication date Feb 24, 2022
    • Mirati Therapeutics, Inc.
    • Ruth Wei Aranda
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMBINATION THERAPIES
    • Publication number 20220040182
    • Publication date Feb 10, 2022
    • Mirati Therapeutics, Inc.
    • Peter Olson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMBINATION THERAPIES
    • Publication number 20220040181
    • Publication date Feb 10, 2022
    • Mirati Therapeutics, Inc.
    • Lars Daniel Engstrom
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

  • Information Trademark

    97874809 - STRA
    • Serial number 97874809
    • Filing date Apr 5, 2023
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97661691 - MTYKA
    • Serial number 97661691
    • Filing date Nov 3, 2022
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97561020 - LIFTYKA
    • Serial number 97561020
    • Filing date Aug 23, 2022
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97561008 - MAVTYKA
    • Serial number 97561008
    • Filing date Aug 23, 2022
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97541653 - KRAZATI
    • Serial number 97541653
    • Registration number 7159329
    • Filing date Aug 9, 2022
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97541596 - KRAZATI
    • Serial number 97541596
    • Registration number 7159328
    • Filing date Aug 9, 2022
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97541729 - KRAZATI
    • Serial number 97541729
    • Registration number 7027981
    • Filing date Aug 9, 2022
    • Mirati Therapeutics, Inc.
    • 42 - Scientific and technological services and research and design relating thereto
  • Information Trademark

    97541672 - KRAZATI
    • Serial number 97541672
    • Registration number 7159330
    • Filing date Aug 9, 2022
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97541713 - KRAZATI
    • Serial number 97541713
    • Registration number 7159331
    • Filing date Aug 9, 2022
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97541695 - KRAZATI
    • Serial number 97541695
    • Registration number 7020760
    • Filing date Aug 9, 2022
    • Mirati Therapeutics, Inc.
    • 42 - Scientific and technological services and research and design relating thereto
  • Information Trademark

    97481214 - MMX
    • Serial number 97481214
    • Registration number 7159306
    • Filing date Jun 29, 2022
    • Mirati Therapeutics, Inc.
    • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • Information Trademark

    97301667 - MTYKEA
    • Serial number 97301667
    • Filing date Mar 8, 2022
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97301650 - MTYEKA
    • Serial number 97301650
    • Filing date Mar 8, 2022
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97240198 - MIRATI & ME
    • Serial number 97240198
    • Registration number 7158867
    • Filing date Jan 26, 2022
    • Mirati Therapeutics, Inc.
    • 36 - Insurance
  • Information Trademark

    97240153 - MIRATI & ME
    • Serial number 97240153
    • Registration number 7158866
    • Filing date Jan 26, 2022
    • Mirati Therapeutics, Inc.
    • 36 - Insurance
  • Information Trademark

    97191230 - KRAZELVI
    • Serial number 97191230
    • Filing date Dec 27, 2021
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    97037315 - M
    • Serial number 97037315
    • Registration number 7020386
    • Filing date Sep 21, 2021
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    90796207 - MIRATI
    • Serial number 90796207
    • Registration number 7164949
    • Filing date Jun 25, 2021
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    90739531 - MIRATI
    • Serial number 90739531
    • Registration number 6659597
    • Filing date May 27, 2021
    • Mirati Therapeutics, Inc.
    • 42 - Scientific and technological services and research and design relating thereto
  • Information Trademark

    90739574 - MIRATI THERAPEUTICS
    • Serial number 90739574
    • Registration number 6713167
    • Filing date May 27, 2021
    • Mirati Therapeutics, Inc.
    • 42 - Scientific and technological services and research and design relating thereto
  • Information Trademark

    90739552 - MIRATI THERAPEUTICS
    • Serial number 90739552
    • Registration number 7019943
    • Filing date May 27, 2021
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    90739406 - M
    • Serial number 90739406
    • Registration number 7019941
    • Filing date May 27, 2021
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    90739463 - M
    • Serial number 90739463
    • Registration number 6659596
    • Filing date May 27, 2021
    • Mirati Therapeutics, Inc.
    • 42 - Scientific and technological services and research and design relating thereto
  • Information Trademark

    90739492 - MIRATI
    • Serial number 90739492
    • Registration number 7019942
    • Filing date May 27, 2021
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    90603920 - BYKRASO
    • Serial number 90603920
    • Filing date Mar 25, 2021
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    90603915 - KRAZATI
    • Serial number 90603915
    • Registration number 7019779
    • Filing date Mar 25, 2021
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    90238399 - KRASLOQ
    • Serial number 90238399
    • Filing date Oct 6, 2020
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    88408985 - MTARGIO
    • Serial number 88408985
    • Filing date Apr 30, 2019
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    88408998 - VYMIRIO
    • Serial number 88408998
    • Filing date Apr 30, 2019
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations
  • Information Trademark

    88408993 - MTAMRIO
    • Serial number 88408993
    • Filing date Apr 30, 2019
    • Mirati Therapeutics, Inc.
    • 5 - Pharmaceutical and veterinary preparations